Correspondence 0001213900-24-057217 from Onconetix, Inc. (ONCO)
Onconetix, Inc.
Date: June 28, 2024 · CIK: 0001782107 · Accession: 0001213900-24-057217
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-277066
Letter
ONCONETIX, INC.
201 E. Fifth Street, Suite 1900
Cincinnati, OH
June 28, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Re:
Onconetix, Inc.
Registration Statement on Form S-1
File No. 333-277066
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. EST on Monday, July 1, 2024, or as soon as practicable thereafter.
Very truly yours,
/s/ Karina M. Fedasz
Show Raw Text
CORRESP
1
filename1.htm
ONCONETIX, INC.
201 E. Fifth Street, Suite 1900
Cincinnati, OH
June 28, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Re:
Onconetix, Inc.
Registration Statement on Form S-1
File No. 333-277066
Ladies and Gentlemen:
Pursuant to Rule 461 under the
Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration
Statement so that it will become effective at 5:00 p.m. EST on Monday, July 1, 2024, or as soon as practicable thereafter.
Very truly yours,
/s/ Karina M. Fedasz
Karina M. Fedasz
Interim Chief Financial Officer
cc:
Ellenoff Grossman & Schole LLP